Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Eymin

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Biochemical Pharmacology|May 18, 2020
Targeting the spliceosome machinery: A new therapeutic axis in cancer?Beatrice Eymin
Cell Adhesion & Migration|February 9, 2010
Role of cell cycle regulators in lung carcinogenesisBeatrice Eymin, Sylvie Gazzeri
Current Opinion in Oncology|November 18, 2015
RNA splicing, cell signaling, and response to therapiesCherine Abou Faycal, Sylvie Gazzeri, Beatrice Eymin
Scientific Reports|January 25, 2019
A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cellsCherine Abou Faycal, Sylvie Gazzeri, Beatrice Eymin
International Journal of Cancer|June 16, 2010
The ARF tumor suppressor: structure, functions and status in cancerPeggy Ozenne, Beatrice Eymin, Elisabeth Brambilla, et al.
Cell Cycle (Georgetown, Tex.)|May 11, 2011
SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell linesValerie Edmond, Christian Brambilla, Elisabeth Brambilla, et al.
Cell Adhesion & Migration|February 9, 2010
Lung cancer: a modified epigenomeArnaud Van Den Broeck, Peggy Ozenne, Beatrice Eymin, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|March 8, 2022
Far beyond anti-angiogenesis: Benefits for anti-basicFGF therapy in cancerChunYan Li, KeLi Kuang, JunRong Du, et al.
Frontiers in Genetics|May 29, 2019
Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer PatientsFlorence de Fraipont, Sylvie Gazzeri, William C Cho, et al.
International Journal of Molecular Sciences|February 18, 2017
Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted TherapyCherine Abou-Fayçal, Anne-Sophie Hatat, Sylvie Gazzeri, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|May 18, 2020
Targeting the spliceosome machinery: A new therapeutic axis in cancer?Beatrice Eymin
Cell Adhesion & Migration|February 9, 2010
Role of cell cycle regulators in lung carcinogenesisBeatrice Eymin, Sylvie Gazzeri
Current Opinion in Oncology|November 18, 2015
RNA splicing, cell signaling, and response to therapiesCherine Abou Faycal, Sylvie Gazzeri, Beatrice Eymin
Scientific Reports|January 25, 2019
A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cellsCherine Abou Faycal, Sylvie Gazzeri, Beatrice Eymin
International Journal of Cancer|June 16, 2010
The ARF tumor suppressor: structure, functions and status in cancerPeggy Ozenne, Beatrice Eymin, Elisabeth Brambilla, et al.
Cell Cycle (Georgetown, Tex.)|May 11, 2011
SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell linesValerie Edmond, Christian Brambilla, Elisabeth Brambilla, et al.
Cell Adhesion & Migration|February 9, 2010
Lung cancer: a modified epigenomeArnaud Van Den Broeck, Peggy Ozenne, Beatrice Eymin, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|March 8, 2022
Far beyond anti-angiogenesis: Benefits for anti-basicFGF therapy in cancerChunYan Li, KeLi Kuang, JunRong Du, et al.
Frontiers in Genetics|May 29, 2019
Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer PatientsFlorence de Fraipont, Sylvie Gazzeri, William C Cho, et al.
International Journal of Molecular Sciences|February 18, 2017
Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted TherapyCherine Abou-Fayçal, Anne-Sophie Hatat, Sylvie Gazzeri, et al.
Pageof 3